PR Newswire - Akeso's Next-Generation HER3 ADC AK138D1 Combined ...
HONG KONG, June 15, 2026 /PRNewswire/ -- Akeso, Inc. (HKEX: 9926) today announced that the first patient has been enrolled in the Phase Ib/II clinical study (AK138D1-202) evaluating its internally dev...
Read More

ภาษาไทย
English